(Q35991573)

11 August 2017

Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer (English)

1 reference

11 August 2017

1 reference

Dowsett M

1

1 reference

11 August 2017

Harris AL

series ordinal

2

1 reference

11 August 2017

Smith IE

series ordinal

3

1 reference

11 August 2017

Jeffcoate SL

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 1984

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

50

1 reference

11 August 2017

3

1 reference

11 August 2017

357-361

1 reference

Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Prognostic significance of serum prolactin levels in advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Steroid Hormone Receptors in Breast Cancer Treatment Strategy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Sex-hormone-binding globulin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Assessment of response to therapy in advanced breast cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Aminoglutethimide Inhibits Extraglandular Estrogen Production in Postmenopausal Women with Breast Carcinoma*

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

The Hormonal Activity of the Postmenopausal Ovary

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Dehydroepiandrosterone and Dehydroepiandrosterone Sulfate Dynamics in Obesity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

1. Estrogen antagonists. Aromatase inhibitors, their pharmacology and application

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Comparison of the biological effects of tamoxifen and a new antioestrogen (LY 117018) on the immature rat uterus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Recurrent breast cancer treated with the antioestrogen tamoxifen: correlation between hormonal changes and clinical course

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Study of steroid-protein binding by a novel “two-tier” column employing cibacron blue F3G-A-Sepharose 4B. I—Sex hormone binding globulin

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Cellular and molecular mechanism of action of antiestrogens.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1976801

Plasma hormones in patients with advanced breast cancer treated with tamoxifen

23 September 2018

1 reference

12 December 2020

Increases in steroid binding globulins induced by tamoxifen in patients with carcinoma of the breast

1 reference

12 December 2020

Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer

1 reference

12 December 2020

The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer

1 reference

12 December 2020

A standardised multicentre procedure for plasma gonadotrophin radioimmunoassay

1 reference

12 December 2020

Aminoglutethimide dose and hormone suppression in advanced breast cancer

1 reference

12 December 2020

Endocrine Changes Associated with Relapse in Advanced Breast Cancer Patients on Aminoglutethimide Therapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1984.183

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

6540595

1 reference